image
Healthcare - Biotechnology - NASDAQ - US
$ 13.49
-3.13 %
$ 1.15 B
Market Cap
-8.01
P/E
CASH FLOW STATEMENT
-93.4 M OPERATING CASH FLOW
-124.77%
-8.44 M INVESTING CASH FLOW
25.22%
195 M FINANCING CASH FLOW
350.11%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Liquidia Corporation
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)(90m)(90m)(100m)(100m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -130 M
Depreciation & Amortization 2.2 M
Capital Expenditures -4.95 M
Stock-Based Compensation 18.8 M
Change in Working Capital 0
Others 16 M
Free Cash Flow -98.4 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (130.4) (78.5) (41.0) (34.6) (59.8) (47.6) (53.1) (29.2) (15.9)
Depreciation & Amortization 2.2 2.2 3.6 5.6 3.1 2.6 1.5 0.9 0.7
Deferred Income Tax 0 0 0 44 K 10.8 K 6.59 K (0.4) (11.9) 0
Stock Based Compensation 18.8 10.1 9.3 6.7 4.0 3.4 2.2 0.5 0.3
Other Operating Activities 16.0 18.8 1.6 0.5 0.2 0.3 17.7 14.9 0.4
Change in Working Capital 0 5.9 (2.2) (12.4) (1.7) (7.0) 0.3 0.4 0.6
Cash From Operations (93.4) (41.6) (28.6) (34.0) (54.1) (48.3) (31.8) (24.3) (13.9)
INVESTING CASH FLOW
Capital Expenditures (4.9) (1.3) (0.6) (0.1) (0.8) (1.9) (0.9) (2.5) (2.9)
Other Items (3.5) (10.0) 5 K 0 1.0 0 0 0 0
Cash From Investing Activities (8.4) (11.3) (0.6) (0.1) 0.2 (1.9) (0.9) (2.5) (2.9)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 52.5 19.4 9.0 (0.4) (6.8) 4.0 (1.4) 30.1 5.7
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 3.6 (0.4) 1.5 5.0 (1.0) (0.6) 22.9 (1.3) 0.4
Cash From Financing Activities 194.7 43.2 65.0 26.3 63.4 66.4 68.8 28.8 6.1
CHANGE IN CASH
Net Change In Cash 92.8 (9.6) 35.8 (7.8) 9.5 16.3 36.1 2.0 (10.7)
FREE CASH FLOW
Free Cash Flow (98.4) (42.9) (29.2) (34.1) (54.9) (50.1) (32.7) (26.8) (16.8)